Personalized lifestyle support with an app for adults seeing their GP for depression symptoms
Official title: A Personalized Lifestyle Intervention for Depression Symptomatology in General Practice - a Cluster Randomized Multicenter Trial
Run by Radboud University Medical Center · NCT07022184 · Data updated 2026-11-12
This study tests whether a smartphone app that supports personalized lifestyle changes can help reduce depression symptoms for adults who visit their GP.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 216 (estimated) |
| Sponsor | Radboud University Medical Center Academic / other |
| Locations | 3 sites (Nijmegen, Gelderland and 2 other locations) |
| Status | Recruiting |
| Started | June 17, 2025 |
| Main results expected | November 2026 |
| Study ends | February 2027 |
| Registry record updated | December 22, 2025 |
| Trial ID | NCT07022184 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults who currently have symptoms of depression and have been receiving treatment for this episode from their GP for less than six months, who speak Dutch and own a smartphone, are the intended participants.
✕Probably not a fit
People with severe mental illness (e.g., psychosis or bipolar disorder), severe substance addiction requiring specialist care, high suicide risk, moderate-to-severe cognitive impairment, or those without a smartphone or sufficient Dutch are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults presenting to general practice with depressive symptoms are randomized by clinic to receive either usual care or usual care plus a personalized lifestyle intervention delivered via a smartphone app. App users complete a questionnaire covering six themes (mental wellbeing, substance use, social relationships, healthy eating, sleep, and physical activity), set personal goals, and receive tailored guidance and self-monitoring prompts. Outcomes include changes in depression symptoms over time and cost-effectiveness compared with usual care alone. The trial is conducted in multiple Dutch academic centers and embedded in routine primary-care settings.
Why it matters
Potential benefit: If successful, the app could reduce depressive symptoms by helping people make and sustain healthy lifestyle changes while increasing the reach and cost-effectiveness of primary care treatment.
How similar studies have gone: Previous research shows lifestyle changes and digital interventions can help mild-to-moderate depression, but few cluster-randomized trials have tested a personalized lifestyle app embedded in general practice.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Currently experiencing an episode of symptoms of depression and receiving treatment for this episode from their GP or GP-MHW for less than six months * Have a smartphone * Be proficient in Dutch Exclusion Criteria: * Severe mental illness (such as psychosis or bipolar disorder) * Severe alcohol or drug addiction requiring specialized secondary care * High suicide risk * moderate to severe cognitive impairment (as determined by the GP) Patients who visit their GP for depressive symptoms but with a PHQ-9 of \<5 at baseline are allowed to use the PLI, but will not be included in the primary analysis.
Where it's running
-
Radboudumc
Nijmegen, Gelderland, Netherlands Recruiting -
Amsterdam UMC
Amsterdam, North Holland, Netherlands Recruiting -
UMC Groningen
Groningen, Provincie Groningen, Netherlands Recruiting
Study contacts
- Study coordinator: Eline Jagtenberg
- Email: eline.jagtenberg@radboudumc.nl
- Phone: 0652902132
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
Aerobic Exercise as an Adjunct Therapy for Depression
This study tests whether adding a structured aerobic exercise program to standard antidepressant and therapy helps reduce depression severity more than standard care alone.
-
Group Unified Protocol for Emotional Disorders in adults in public mental health (UP in Spanish)
A group-based Spanish version of the Unified Protocol is being tested with adults in public mental health to see if it helps anxiety, depression, and related symptoms.
-
Metformin added to antidepressants for depression with obesity in Pakistani adults
This study tests whether adding metformin to antidepressant therapy helps reduce depressive symptoms and BMI in adults with depression and overweight/obesity in Pakistan.
-
Parent group program using the Unified Protocol for teens with autism and anxiety/depression
This trial tests a parent-guided adaptation of the Unified Protocol to help adolescents with autism and co-occurring anxiety or depression.
-
Mindfulness‑augmented brain stimulation for treatment‑resistant depression
This trial will test whether combining fast brain stimulation (iTBS) with a digital mindfulness program helps people with treatment‑resistant depression reduce symptoms and improve thinking.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.